Download MendeleyRecombinant antibodies inhibit enzymatic activity of the E3 ubiquitin ligase CHIP via multiple mechanisms.
Chung, D.H., Connelly, E.J., Unnikrishnan, A., Chuo, S.W., Wucherer, K., Nadel, C.M., Gestwicki, J.E., Southworth, D.R., Craik, C.S.(2025) J Biological Chem 301: 108220-108220
- PubMed: 39863102
- DOI: https://doi.org/10.1016/j.jbc.2025.108220
- Primary Citation of Related Structures:
9DRY - PubMed Abstract:
Carboxyl-terminus of Hsp70-Interacting Protein (CHIP) is an E3 ubiquitin ligase that marks misfolded substrates for degradation. Hyper-activation of CHIP has been implicated in multiple diseases, including cystic fibrosis and cancer, suggesting that it may be a potential drug target. However, there are few tools available for exploring this possibility. Moreover, the best ways of inhibiting CHIP's function are not obvious, as this complex protein is composed of a tetratricopeptide repeat (TPR) domain, a U-box domain, and a coiled-coil domain that mediates homodimerization. To probe the structure and function of CHIP, we report an antibody panning campaign that yielded six recombinant Fabs with affinity for CHIP. Interestingly, these antibodies varied in their binding site(s) and impact on CHIP function, such as inhibiting TPR interactions, autoubiquitination, and/or substrate ubiquitination. Of particular interest, antibody 2F1 nearly eliminated substrate binding (IC 50 = 2.7 μM) and limited ubiquitination and autoubiquitination. Cryo-electron microscopy of the 2F1:CHIP complex revealed a 2:1 binding mode (Fab:CHIP dimer), with 2F1 bound to the U-box domain and simultaneously displacing the TPR domain. Together, these studies provide insight into ways of inhibiting CHIP's activity and provide a series of new probes for exploring the function of this important E3 ubiquitin ligase.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA. Electronic address: dhnc86@gmail.com.
Organizational Affiliation:
